Uwe Treiber
Overview
Explore the profile of Uwe Treiber including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
473
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schwarzenbock S, Eiber M, Kundt G, Retz M, Sakretz M, Kurth J, et al.
Eur J Nucl Med Mol Imaging
. 2016 Jun;
43(12):2105-2113.
PMID: 27317482
Purpose: The aim of this study was to prospectively evaluate the value of [C] Choline PET/CT in monitoring early and late response to a standardized first-line docetaxel chemotherapy in castration...
2.
Schwarzenbock S, Schmeja P, Kurth J, Souvatzoglou M, Nawroth R, Treiber U, et al.
Mol Imaging Biol
. 2015 Oct;
18(3):393-401.
PMID: 26483088
Purpose: Carbon-11- and fluorine-18-labeled choline derivatives are commonly used in prostate cancer imaging in the clinical setting for staging and re-staging of prostate cancer. Due to a limited detection rate...
3.
Grosu A, Weirich G, Wendl C, Prokic V, Kirste S, Geinitz H, et al.
Eur J Nucl Med Mol Imaging
. 2014 Sep;
41(12):2242-8.
PMID: 25186430
Purpose: The aim of this study was to develop a methodology for the comparison of pathology specimens after prostatectomy (post-S) with PET images obtained before surgery (pre-S). This method was...
4.
Schwarzenbock S, Gertz J, Souvatzoglou M, Kurth J, Sachs D, Nawroth R, et al.
Mol Imaging Biol
. 2014 Aug;
17(2):248-56.
PMID: 25163420
Purpose: Carbon-11- and fluorine-18-labeled choline derivatives have been introduced as promising tracers for prostate cancer imaging. However, due to limited specificity and sensitivity, there is a need for new tracers...
5.
Maurer T, Horn T, Souvatzoglou M, Eiber M, Beer A, Heck M, et al.
Urol Int
. 2014 Jul;
93(2):207-13.
PMID: 25012094
Background: In patients with bladder cancer (BCa) preoperative staging with (11)C-choline positron emission tomography-computed tomography (PET/CT) could be used to derive prognostic information and hence stratify patients preoperatively with respect...
6.
Thalgott M, Horn T, Heck M, Maurer T, Eiber M, Retz M, et al.
J Hematol Oncol
. 2014 Mar;
7:20.
PMID: 24598155
Background: Patients with locally advanced and high-risk prostate cancer (LAPC) are prone to experience biochemical recurrence despite radical prostatectomy (RP). We evaluated feasibility, safety and activity of a neoadjuvant chemohormonal...
7.
Schmid S, Schuster T, Horn T, Gschwend J, Treiber U, Weirich G
Anticancer Res
. 2013 Sep;
33(9):3731-7.
PMID: 24023303
Background: Platinum-based chemotherapy is the treatment of choice for metastatic urothelial carcinoma, which is limited by primary and secondary resistance of the tumour. The Cu(2+) transporting beta polypeptide ATPase (ATP7B)...
8.
Bundschuh R, Wendl C, Weirich G, Eiber M, Souvatzoglou M, Treiber U, et al.
Eur J Nucl Med Mol Imaging
. 2013 Feb;
40(6):824-31.
PMID: 23389430
Purpose: PET has been proven to be helpful in the delineation of gross tumour volume (GTV) for external radiation therapy in several tumour entities. The aim of this study was...
9.
Hatzichristodoulou G, Kubler H, Schwaibold H, Wagenpfeil S, Eibauer C, Hofer C, et al.
Anticancer Res
. 2012 Nov;
32(11):5093-7.
PMID: 23155286
Aim: To compare nuclear matrix protein 22 expression by BladderChek® and ELISA, as urine-based assays for bladder cancer (BC) detection. Patients And Methods: Urine samples of 100 BC patients and...
10.
Herkommer K, Hofer C, Gschwend J, Kron M, Treiber U
J Urol
. 2012 Mar;
187(5):1566-70.
PMID: 22425072
Purpose: Bladder cancer is the second most common tumor of the genitourinary system. Although transurethral resection is the standard diagnostic and therapeutic procedure, it is not morbidity free. Bladder perforation...